Answer
Pregnancy use is generally avoided as a precaution unless specialist assessment supports it. Product information advises against breastfeeding during treatment.
Sources for this answer
- Octreotide 50 micrograms/1 ml Solution for Injection — Current selected SmPCemc · Summary of Product Characteristics
- Olatuton 30 mg Powder and Solvent for Prolonged-release Suspension for Injection — Current selected SmPCemc · Summary of Product Characteristics